<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04550754</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0430</org_study_id>
    <nct_id>NCT04550754</nct_id>
  </id_info>
  <brief_title>Evaluation of the Management of Tramadol Use Disorders</brief_title>
  <official_title>Evaluation of the Medical Management of Tramadol Use Disorders in Patients Hospitalized for Tramadol Withdrawal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In France, In recent years, there has been a steady increase in reports of abuse and&#xD;
      dependence on tramadol. Over 50% of tramadol withdrawal syndromes involve taking tramadol in&#xD;
      therapeutic doses, sometimes for short periods of less than a week. Physical dependence can&#xD;
      develop when a therapeutic maintenance dose is prescribed for the treatment of mild to&#xD;
      moderate pain. Due to its mixed mechanism of action, tramadol withdrawal syndromes are not&#xD;
      only characterized by classic signs of opioid withdrawal (muscle pain, mydriasis, sweating,&#xD;
      nausea and vomiting, tearing, rhinorrhea, yawning, fever, insomnia, etc.). The properties of&#xD;
      this substance on serotonin explain the effects which are added to the morphine-mimetic&#xD;
      withdrawal of tramadol. Analysis of spontaneous reports shows &quot;psychological and psychic&quot;&#xD;
      signs of withdrawal. Currently, there is no validated protocol for the management of tramadol&#xD;
      withdrawal. The main objective is to assess the different options for managing tramadol&#xD;
      withdrawal: opioid maintenance therapy and symptomatic treatments, in relation to the&#xD;
      addictive and psychiatric co-morbidities in patients. The study also provides insight into&#xD;
      the different types of withdrawal syndromes experienced by patients in order to raise&#xD;
      awareness among doctors when prescribing tramadol.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 17, 2020</start_date>
  <completion_date type="Actual">June 1, 2021</completion_date>
  <primary_completion_date type="Actual">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Medical Management of Tramadol withdrawal syndrome</measure>
    <time_frame>1 day</time_frame>
    <description>Management by substitution drugs, by therapeutic degrowth</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tramadol withdrawal syndrome experienced by patients</measure>
    <time_frame>1 day</time_frame>
    <description>Description of classic cpioid withdrawal symptoms and atypical aymptoms apecific to</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Withdrawal</condition>
  <arm_group>
    <arm_group_label>Patients hospitalized for tramadol withdrawal</arm_group_label>
    <description>Patients hospitalized for tramadol withdrawal in Montpellier University Hospital and Nîmes University Hospital from 01/01/2015 to 31/12/2019</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adults hospitalized in Montpellier University Hospital and Nîmes University Hospital for&#xD;
        Tramadol withdrawal&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  &gt;18 years old&#xD;
&#xD;
          -  Tramadol actual misuse/addiction&#xD;
&#xD;
          -  Patients hospitalized for Tramadol withdrawal&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  &lt;18 years old&#xD;
&#xD;
          -  History of misuse or addiction for tramadol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hélène Peyrière, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>UH Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34290</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 3, 2020</study_first_submitted>
  <study_first_submitted_qc>September 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Substance use disorder</keyword>
  <keyword>Programme de Medicalisation des Systèmes d'Information</keyword>
  <keyword>tramadol</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

